529 related articles for article (PubMed ID: 25359856)
21. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
22. Renal cystic disease in the Fbn1
Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
[TBL] [Abstract][Full Text] [Related]
23. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
[TBL] [Abstract][Full Text] [Related]
24. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
[TBL] [Abstract][Full Text] [Related]
25. Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.
Okamura H; Pisani LJ; Dalal AR; Emrich F; Dake BA; Arakawa M; Onthank DC; Cesati RR; Robinson SP; Milanesi M; Kotek G; Smit H; Connolly AJ; Adachi H; McConnell MV; Fischbein MP
Circ Cardiovasc Imaging; 2014 Jul; 7(4):690-6. PubMed ID: 24814820
[TBL] [Abstract][Full Text] [Related]
26. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
27. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
28. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
29. AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome.
Remes A; Arif R; Franz M; Jungmann A; Zaradzki M; Puehler T; Heckmann MB; Frey N; Karck M; Kallenbach K; Hecker M; Müller OJ; Wagner AH
Cardiovasc Res; 2021 Nov; 117(12):2459-2473. PubMed ID: 33471064
[TBL] [Abstract][Full Text] [Related]
30. Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm.
Oller J; Gabandé-Rodríguez E; Ruiz-Rodríguez MJ; Desdín-Micó G; Aranda JF; Rodrigues-Diez R; Ballesteros-Martínez C; Blanco EM; Roldan-Montero R; Acuña P; Forteza Gil A; Martín-López CE; Nistal JF; Lino Cardenas CL; Lindsay ME; Martín-Ventura JL; Briones AM; Redondo JM; Mittelbrunn M
Circulation; 2021 May; 143(21):2091-2109. PubMed ID: 33709773
[TBL] [Abstract][Full Text] [Related]
31. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.
Crosas-Molist E; Meirelles T; López-Luque J; Serra-Peinado C; Selva J; Caja L; Gorbenko Del Blanco D; Uriarte JJ; Bertran E; Mendizábal Y; Hernández V; García-Calero C; Busnadiego O; Condom E; Toral D; Castellà M; Forteza A; Navajas D; Sarri E; Rodríguez-Pascual F; Dietz HC; Fabregat I; Egea G
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):960-72. PubMed ID: 25593132
[TBL] [Abstract][Full Text] [Related]
32. Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling Pathway.
Sato T; Arakawa M; Tashima Y; Tsuboi E; Burdon G; Trojan J; Koyano T; Youn YN; Penov K; Pedroza AJ; Shabazzi M; Palmon I; Nguyen MN; Connolly AJ; Yamaguchi A; Fischbein MP
J Am Heart Assoc; 2018 Nov; 7(21):e008543. PubMed ID: 30571378
[TBL] [Abstract][Full Text] [Related]
33. Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice.
LeMaire SA; Zhang L; Zhang NS; Luo W; Barrish JP; Zhang Q; Coselli JS; Shen YH
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):e215-e226. PubMed ID: 34586071
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
35. Pravastatin reduces Marfan aortic dilation.
McLoughlin D; McGuinness J; Byrne J; Terzo E; Huuskonen V; McAllister H; Black A; Kearney S; Kay E; Hill AD; Dietz HC; Redmond JM
Circulation; 2011 Sep; 124(11 Suppl):S168-73. PubMed ID: 21911808
[TBL] [Abstract][Full Text] [Related]
36. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
[TBL] [Abstract][Full Text] [Related]
37. Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
Chung AW; Yang HH; van Breemen C
Br J Pharmacol; 2007 Oct; 152(3):305-12. PubMed ID: 17641673
[TBL] [Abstract][Full Text] [Related]
38. A FBN1 3'UTR mutation variant is associated with endoplasmic reticulum stress in aortic aneurysm in Marfan syndrome.
Siegert AM; García Díaz-Barriga G; Esteve-Codina A; Navas-Madroñal M; Gorbenko Del Blanco D; Alberch J; Heath S; Galán M; Egea G
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):107-114. PubMed ID: 30385411
[TBL] [Abstract][Full Text] [Related]
39. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights.
Furthmayr H; Francke U
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339
[TBL] [Abstract][Full Text] [Related]
40. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome.
Franken R; Teixido-Tura G; Brion M; Forteza A; Rodriguez-Palomares J; Gutierrez L; Garcia Dorado D; Pals G; Mulder BJ; Evangelista A
Heart; 2017 Nov; 103(22):1795-1799. PubMed ID: 28468757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
